Skip to main content
. 2022 Apr 28;37(1):1241–1256. doi: 10.1080/14756366.2022.2068147

Figure 3.

Figure 3.

The rational of novel NMDA receptor modulators and acetylcholinesterase (AChE) inhibitors.